Indeed, Gabra3, AKT/mTOR and JNK pathway markers (p-p70s6k, MMP-2 and MMP-9) were obviously increased in PC patients with advanced TNM stages according to IHC analyses (Fig. 7a). This evidence concerns the gene MMP2 and pachyonychia congenita.